Home › Funds › Solel Partners LP › CVS
Solel Partners LP position in CVS
CVS HEALTH CORP · Consumer Staples
Solel Partners LP reported holding 39,400 shares of CVS (CVS HEALTH CORP) in its Q2 2026 13F filing — a position valued at US$4.1M, representing 0.69% of its reported portfolio and ranking #20 among its reported holdings. Solel Partners LP has disclosed CVS holdings in 9 of the last 9 reported quarters, going back to Q2 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Solel Partners LP's CVS position evolved
Solel Partners LP first disclosed a stake in CVS in Q2 2024 at 503,400 shares (US$29.7M). The position peaked in Q3 2024 at 1,128,900 shares, worth US$71.0M. Across 9 filings, Solel Partners LP increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 39,400 shares valued at US$4.1M — a reduction of -454,300 shares quarter over quarter.. Notable position changes include a 124% increase in Q3 2024 (shares fell 28% over the following quarter), a 46% trim in Q1 2025 (shares rose 3% over the following quarter), a 92% trim in Q2 2026 (shares fell 17% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 503.40K | $29.73M | New |
| Q3 2024 | 1.13M | $70.99M | Add |
| Q4 2024 | 1.42M | $63.94M | Add |
| Q1 2025 | 774.30K | $52.46M | Reduce |
| Q2 2025 | 674.30K | $46.51M | Reduce |
| Q3 2025 | 713.70K | $53.81M | Add |
| Q4 2025 | 593.70K | $47.12M | Reduce |
| Q1 2026 | 493.70K | $35.46M | Reduce |
| Q2 2026 | 39.40K | $4.08M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CVS and 13F data
CVS (CVS HEALTH CORP) is a Consumer Staples company. 39 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$7.75B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CVS
- Capital World Investors 74.95M sh · $7.75B · Q2 2026
- Capital World Investors 74.95M sh · $7.75B · Q2 2026
- Dodge & Cox 50.01M sh · $5.17B · Q2 2026
- DODGE & COX 50.01M sh · $5.17B · Q2 2026
- Wellington Management Group 33.80M sh · $3.50B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 33.80M sh · $3.50B · Q2 2026
- DAVIS SELECTED ADVISERS 11.87M sh · $1.23B · Q2 2026
- Pzena Investment Management 11.77M sh · $1.22B · Q2 2026
- Clearbridge Investments, LLC 8.54M sh · $883.12M · Q2 2026
- GQG Partners LLC 7.96M sh · $822.99M · Q2 2026
More on Solel Partners LP
FAQ
How long has Solel Partners LP held CVS?
Solel Partners LP has disclosed CVS holdings in 9 of the last 9 reported quarters, going back to Q2 2024.
What is Solel Partners LP's current position in CVS?
As of Q2 2026, Solel Partners LP holds 39.40K shares of CVS (CVS HEALTH CORP), valued at $4.08M, representing 0.69% of its reported portfolio and ranking #20.
Has Solel Partners LP been buying or selling CVS?
In the latest 13F filing (Q2 2026), Solel Partners LP reduced its position in CVS. The position peaked in Q3 2024 at 1.13M shares.
Which other funds hold CVS?
Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.